Paragraph 3

Clinical signs consistent with FMD are observed in an animal of a susceptible species and the animal or its cohorts are positive for antibody to FMD virus structural or non-structural proteins, in circumstances where previous vaccination, residual maternal antibodies or non-specific reactions can be excluded as possible causes of seropositivity.